Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,822Revenue $M3,050Net Margin (%)22.6Z-Score4.0
Enterprise Value $M11,161EPS $8.4Operating Margin %39.8F-Score6
P/E(ttm))16.1Cash Flow Per Share $8.0Pre-tax Margin (%)39.8Higher ROA y-yY
Price/Book5.110-y EBITDA Growth Rate %13.9Quick Ratio2.6Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %19.5Current Ratio3.6Lower Leverage y-yY
Price/Cash Flow12.2y-y EBITDA Growth Rate %63.9ROA % (ttm)13.7Higher Current Ratio y-yN
Dividend Yield %0.6Insider Buy (3m)0ROE % (ttm)33.0Less Shares Outstanding y-yY
Payout Ratio %10.0Shares Outstanding M79.2ROI % (ttm)5.1Gross Margin Increase y-yN

Gurus Latest Trades with BCR

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRYacktman Focused Fund 2014-03-31 Reduce-0.91%$125.42 - $146.57
($137.91)
$ 139.491%Reduce -21.67%2,350,000
BCRVanguard Health Care Fund 2013-12-31 Buy 0.13%$113.84 - $139.85
($132.09)
$ 139.496%New holding, 303700 sh.303,700
BCRYacktman Focused Fund 2013-12-31 Reduce-1.7%$113.84 - $139.85
($132.09)
$ 139.496%Reduce -29.91%3,000,000
BCRDonald Yacktman 2013-12-31 Reduce-1.09%$113.84 - $139.85
($132.09)
$ 139.496%Reduce -21.46%7,755,464
BCRYacktman Fund 2013-12-31 Reduce-0.45%$113.84 - $139.85
($132.09)
$ 139.496%Reduce -9.89%3,500,000
BCRRay Dalio 2013-12-31 Reduce-0.01%$113.84 - $139.85
($132.09)
$ 139.496%Reduce -30.54%19,786
BCRRay Dalio 2013-09-30 Add0.01%$107.3 - $120.55
($114.78)
$ 139.4922%Add 24.47%28,486
BCRJeff Ubben 2013-09-30 Sold Out -0.85%$107.3 - $120.55
($114.78)
$ 139.4922%Sold Out0
BCRJoel Greenblatt 2013-09-30 Reduce-0.07%$107.3 - $120.55
($114.78)
$ 139.4922%Reduce -47.69%15,933
BCRYacktman Focused Fund 2013-06-30 Add1.26%$98.25 - $111.8
($104.06)
$ 139.4934%Add 27.8%4,280,000
BCRYacktman Fund 2013-06-30 Add1.06%$98.25 - $111.8
($104.06)
$ 139.4934%Add 29.9%3,884,100
BCRDonald Yacktman 2013-06-30 Add1%$98.25 - $111.8
($104.06)
$ 139.4934%Add 24.46%9,973,185
BCRJoel Greenblatt 2013-06-30 Add0.03%$98.25 - $111.8
($104.06)
$ 139.4934%Add 25.09%30,459
BCRJeff Ubben 2013-06-30 Reduce-3.24%$98.25 - $111.8
($104.06)
$ 139.4934%Reduce -79.02%758,704
BCRRay Dalio 2013-06-30 Reduce-0.04%$98.25 - $111.8
($104.06)
$ 139.4934%Reduce -65.99%22,886
BCRYacktman Focused Fund 2013-03-31 Add0.36%$97.74 - $103.51
($100.89)
$ 139.4938%Add 8.36%3,348,994
BCRDonald Yacktman 2013-03-31 Add0.31%$97.74 - $103.51
($100.89)
$ 139.4938%Add 8.23%8,012,992
BCRYacktman Fund 2013-03-31 Add0.17%$97.74 - $103.51
($100.89)
$ 139.4938%Add 4.91%2,990,000
BCRRay Dalio 2013-03-31 Buy 0.06%$97.74 - $103.51
($100.89)
$ 139.4938%New holding, 67286 sh.67,286
BCRJeff Ubben 2013-03-31 Reduce-0.82%$97.74 - $103.51
($100.89)
$ 139.4938%Reduce -15.52%3,616,308
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BCR Yacktman Fund 2014-03-313,424,6004.334.5-2.15%
BCR Yacktman Focused Fund 2014-03-312,350,0002.973.6-21.67%
BCR Vanguard Health Care Fund 2013-12-31303,7000.380.13New Buy
BCR Yacktman Fund 2013-12-313,500,0004.424.3-9.89%
BCR Joel Greenblatt 2013-12-3114,1520.020.05-11.18%
BCR Donald Yacktman 2013-12-317,755,4649.84.3-21.46%
BCR Yacktman Focused Fund 2013-12-313,000,0003.794.2-29.91%
BCR Ray Dalio 2013-12-3119,7860.020.02-30.54%
Premium Most recent portfolio changes are included for Premium Members only!


BCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
RING TIMOTHY MChairman and CEO 2014-04-01Sell10,231$149.22-6.94view
RING TIMOTHY MChairman and CEO 2014-03-03Sell10,231$142.23-2.36view
Luboff Sharon MGroup Vice President 2014-02-27Sell9,914$144.86-4.14view
Christian Patricia GVP -Quality, Reg & Med Affairs 2014-02-26Sell7,359$142.79-2.75view
KELLY BRONWEN KVP - Human Resources 2014-02-25Sell2,917$141.99-2.2view
RING TIMOTHY MChairman and CEO 2014-02-24Sell6,760$142.85-2.79view
Lupisella Frank JrVice President and Controller 2014-02-20Sell2,520$140.26-0.99view
Naughton Gail KDirector 2014-02-19Sell800$140.63-1.25view
BRESLAWSKY MARC CDirector 2014-02-18Sell2,400$141.34-1.75view
WEILAND JOHN HPresident and COO 2014-02-14Sell73,386$138.670.14view

Press Releases about BCR :

    Quarterly/Annual Reports about BCR:

    News about BCR:

    Articles On GuruFocus.com
    CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
    Yacktman Funds Comments on C.R. Bard Inc. Mar 12 2014 
    Yacktman Fund Comments on C.R. Bard Inc. Jan 30 2014 
    Yacktman Focused Fund & Yacktman Fund Fourth Quarter Commentary Jan 30 2014 
    Weekly Insider Sells Highlight: BCR, GLUU, AMT, APOL, JACK Jan 20 2014 
    Yacktman Fund Buys Oracle, Exxon Mobil, C.R. Bard, Sells Pfizer, Viacom, Microsoft Jul 17 2013 
    The Yacktman Fund's Top 5 Second Quarter Increases Jul 16 2013 
    My 3 Favorite Stocks with Recent Dividend Growth Jun 16 2013 
    Covidien – Positive Results for Life Jun 09 2013 
    Becton, Dickinson and Co. (BDX) Dividend Stock Analysis Jun 07 2013 

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Hide